Description

ITRASPORAX 100 CAP is an oral antifungal medicine formulated with Itraconazole 100 mg, belonging to the triazole class of antifungals. It is widely used for the treatment and prevention of fungal infections affecting the skin, nails, mucous membranes, and internal organs.

Itraconazole works by inhibiting the enzyme lanosterol 14α-demethylase, which is involved in ergosterol synthesis, a crucial component of fungal cell membranes. Disruption of ergosterol synthesis leads to cell membrane damage and fungal cell death.

It is effective in the treatment of onychomycosis, vaginal candidiasis, aspergillosis, histoplasmosis, and systemic mycoses, and is also used as prophylaxis in immunocompromised patients such as those undergoing chemotherapy or organ transplant.

Therapeutic Uses:

• Dermatophytosis and skin fungal infections

• Fungal nail infections (onychomycosis)

• Vaginal and oral candidiasis

• Systemic fungal infections (e.g., aspergillosis, blastomycosis)

• Fungal prophylaxis in immunosuppressed patients

Key Benefits:

• Broad-spectrum antifungal activity

• Effective for both superficial and deep fungal infections

• Suitable for pulse therapy and long-term use

• High tissue penetration and prolonged action

• Manufactured in WHO-GMP compliant facilities

ITRASPORAX 100 CAP is manufactured under WHO-GMP and ISO-certified conditions and is represented and exported by BLUEPILL EXPRESS, a global supplier of quality pharmaceuticals. The product is available in bulk and retail packaging and distributed in international markets including Asia, Africa, the Middle East, Europe, and Latin America, with complete regulatory and export documentation.